The Early Diagnosis of Gastrointestinal Cancers: From Canine Sniffing to Volatile Gas Analysis
ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY JUNIPER PUBLISHERS
Authored by Nishant Shukla
Abstract
The innovative approach in using dogs to detect early cancer had paved the way for the laboratory detection of these volatile substances smelled by the dogs to overcome the inconvenient and non-practical use of dogs in clinical practices, although it can be a desirable approach in areas with limited resources or limited access, like the poor developing countries.
Keywords: Cancer; Volatile substances; Patients; Sweat; Medicine; Medical funds; Prostate cancer
Abbrevations:Cancer; Volatile substances; Patients; Sweat; Medicine; Medical funds; Prostate cancer
Introduction
The sensitive canine sense of smell (termed sometimes as electronic noses) had been used to use dogs to detect the odor of volatile compounds characteristic of patients with cancer by smelling breath, urine, stool of sweat, a principle like the use of these animals for criminal detection purposes. A variety of animal species were used in medicine to detect diseases, such as tuberculosis and cancer [1-5]. This method has the greatest appeal in communities where medical funds and accessibility are limiting, in diagnosis of serious disease for which no screening programs exist or the current biomarkers are not ideal. Dogs are trained to recognize the smell of skin, breath or urine samples from patient with different kinds of cancers including colorectal, pancreatic, breast, prostate, melanoma & lung cancers. The dog’s sniff is the most scent-detector “device” and have the potential to offer a noninvasive alternative to PSA sampling and prostate biopsy for detecting Prostate cancer. This method for the screening of tumor in human body is a painless, noninvasive and fast method & does not need the biochemical analysis in clinical laboratories. It uses the odors that emanate from urine, breath, and feces. These compounds are metabolic products and/or consequence of bacterial dysbiosis produced by the disease state. The accuracy of canine scent detection was even higher for early-stage colorectal cancers and Canine scent detection was not confounded by current smoking, benign colorectal disease, inflammatory disease or the presence of human hemoglobin or transferring. Dogs can be trained to distinguish patients with bladder cancer on the basis of urine odour more successfully than would be expected by chance alone, suggesting that tumor related volatile compounds are present in urine, with characteristic odour signature distinct from those associated with secondary effects of the tumor, such as bleeding, inflammation, and infection. A positive correlation was found between dog sniff of or lung cancer detection and the ethyl acetate and 2-pentanone content of breath detected by chromatography. The methods presented for detection of lung cancer markers in exhaled air could be used as a potential non-invasive tool for screening and the canine method is relatively simple and inexpensive in comparison with chromatography [6-8].
Since the use of dogs to smell humans to detect their cancer early, seems to be not practical, unconventional and unsuitable for clinical application, but provide inspiration for more traditional laboratory investigations and there were trials to find the volatile substances smelled by dogs and analyze them in the laboratory. Analysis of substances present in exhaled breath is easier to perform, faster and non-invasive than serum biomarkers used for cancer detection. Several volatile organic compounds (VOCs) recognized as potential cancer biomarkers, by different analytical techniques are used such as gas chromatography coupled with mass spectrometry (GC/MS), ion flow tube mass spectrometry (SIFT-MS), proton transfer reaction mass spectrometry (PTR-MS) and ion mobility spectrometry (IMS). Urine specimens were recently used to discriminate healthy individuals from patients with pancreatic ductal adenocarcinoma through the detection of Volatile Organic Compounds, with the ability to separate healthy from early stage and early stage versus advanced disease [8-11].
For more articles in Advanced Research in Gastroenterology & Hepatology please click on https://juniperpublishers.com/argh/index.php
For more about Juniper Publishers please click on: https://juniperpublishers.com/video-articles.php
Comments
Post a Comment